Functionally, the result of the EdU assay showed that the RAD51 inhibitor B02 significantly decreased the proliferation of CCA cells induced by HMGA1 (Fig. 7A and Fig. S5A). This evidence concerns the gene HMGA1 and cholangiocarcinoma.